ADI Violates FDA - "Monitor Multiple People's Body Temperatures At Once"

By Conor Healy and John Honovich, Published Mar 09, 2021, 09:02am EST

ADI is touting body temperature detection systems despite the fact that the US FDA has publicly warned against such usage.

IPVM Image

ADI, as the world's largest security systems distributor, with $2+ billion annual sales, has significant power over products sold and setting expectations among dealers, integrators, and installers.

Inside this note, we examine what ADI is marketing, what the FDA's position is and how ADI's negligence fosters wasted money and decreased public safety.

ADI *********

*** "***** ** ********* *** Thermal ****** ******* *******"********:

IPVM Image

** ******** *** *********, ADI ************ ******* *** says **** ****** ** respond. *******, ** ** publication, *** *** *** retracted ** ******* **** guide.

[****** ***** ****: *** has ******* *** **** 'multiple'.]

***'* ******* ******* *********** *** ******** *** with *** ******* ** heavily ******* ***-*** ******* fever *******, ** **** excerpt **** ***** *** 2020 **** **** *****:

IPVM Image

**** ********* **** ** 2021, ** *** ******* promotion ** *** ***** / ***** *** ********** temperature ******* ***** *****:

IPVM Image

FDA ****** *** ******* ******* ******** ****** ********

**** ****,*** *** ****** * public ********* "******** *** *** marketing" ** ********, ***** described ********** ******* **** multi-person *********. ************, *** FDA ****** *** ********* multiple ******, *********:

************* **** ****** ** be ******* ***** ******* imaging *******scan ******** *********** simultaneously....

*** *** ** **** aware **** **** ***** are *********unapproved, ********* *** ************ thermal imaging devices intended to measure human body temperature, including measuring multiple ***********’ ************ ************** [emphasis added]

** ***, ** ******* have ******** ******* ******* from *** ******, *** marketing ** *****-****** ********* was ****** ** ** issue ** ***. ******* Maisel, * ***** ******* Officer ** *** ***, stated:

Improper *** *** ********* ** ******* ******* ******* *** **** ** ********** *********** ******** *** **** * ********* ****** ** ****** ******. As part of the FDA’s ongoing commitment to transparency to the American public, the agency is providing important information to users about the correct use of these devices and is warning certain firms that the *** **** *** ******** ***** ********* ** ********** *** *********** ********. [emphasis added]

*** ***'* ****** **** as*** ********** **** ************* ****-******** **** ********, ***** ***** * temperature ************ ************ ********* at **** ** ******* popular *********** ********* *******.

ADI **** ******* **** ******

***** ******* ******** ********* have *** ******* **** safety ** ********* *********** screening **** ******** ********** and *** **********, *** has ******** ********* ***** its ***** **** *** the ********* ** ******** vet **** **** ****, if **** ** *******.

*** ** ****, ** not *****, ** ****** boxes *** ******* ***** promotions. *** *** ***** make *** ***** * safer *** **** ****** if **** ****** ***** moderately **** ********* *** time ** ******** *** and ********** ****** **** they *****.

Comments (8)

******* *** **** **** introduce ***** *** ******* products **** **** **** temperature **** *** ******** based ** **** ****** expressions & ******.

Agree: 2
Disagree
Informative
Unhelpful
Funny: 6

*** ***** *** *** funny *** **** ***** ADI ******* *** ****** a *-*** ***** ****** before ******* **, ********* from **** ****:

IPVM Image

Agree
Disagree
Informative: 2
Unhelpful: 1
Funny: 1

********, ** *** *****. A ***** ** ***** helps...

Agree
Disagree
Informative
Unhelpful
Funny

** **** **** *** 510k ******* ** ***-******** models?

Agree
Disagree
Informative
Unhelpful
Funny

*** *** *** ******* marketing ** ******** ****** screening. *** **** *** been ******* ** ***:

******* ********** ********* *******, thermal ********** ** *** other ******** ********, *** should ****** *** *** proper ********** ****** ***-** and ********* ** ****** the *********** ***. ************, the *.*. **** *** Drug ************** ********** **** limitations ** ******* ********** when **** ** **** the *********** ** ******** people ** *** **** time, *** **** ****** be ***** **** ************* for *** *************.

Agree: 1
Disagree
Informative: 2
Unhelpful
Funny

*****; ******* ******.

Agree
Disagree
Informative
Unhelpful
Funny: 1

*** ******* ** **** ADI's ****** ** ********* and ********* **** **** guided **** *****-****** *********** screening ** ********. ******** words ** *** ***** ADI ***** **.

Agree: 1
Disagree
Informative
Unhelpful
Funny

**** ** ***; **** this ********* ** ****** to **** ***** ** the ******* ** *** foolish **** ******* ** use *** ********** **** such * *** ***** record ** ********** ********** in *** ***** *****. We ******* *** **** better **** ****....**** ** we ****'*, *** ** sounded **** ** ** head.

Agree
Disagree
Informative
Unhelpful
Funny: 1
Read this IPVM report for free.

This article is part of IPVM's 7,324 reports and 971 tests and is only available to subscribers. To get a one-time preview of our work, enter your work email to access the full article.

Already a subscriber? Login here | Join now
Loading Related Reports